Broadcom: Get Ready For A Breakout

Broadcom reported Q3 FY2026 revenue growth of 86% year over year, driven by a 221% surge in AI semiconductor revenue, while adjusted EPS increased 96%. Although a more hardware-heavy mix compressed gross margin, expense discipline supported a 68% non-GAAP operating margin. The analyst maintained a buy rating, citing a 29.85 forward P/E and expectations for AI revenue to quadruple by FY2028.

Analysis

The key underwriting question is no longer AI revenue growth but whether AVGO can preserve a software-like earnings multiple while its incremental mix becomes more hardware-intensive. If custom ASIC and networking growth continues to outrun VMware, gross-margin dilution could cap multiple expansion even as EPS revisions rise; this favors owning AVGO against higher-multiple AI infrastructure peers whose estimates are more dependent on sustained GPU scarcity. The underappreciated offset is operating leverage: disciplined opex means a modest upside to revenue can still produce disproportionate EPS and FCF upside over the next 1-3 quarters.

Competitive dynamics are bifurcating. AVGO is a direct beneficiary of hyperscalers diversifying compute away from merchant GPUs toward internally designed accelerators, creating potential share pressure for NVDA at the margin and a more acute risk for MARV, whose custom-silicon narrative has fewer proven scaled deployments. Conversely, AVGO's AI supply chain remains concentrated in a small number of cloud customers; a single program delay, inventory digestion cycle, or a shift in accelerator architecture could materially affect quarterly expectations because custom chips have long qualification cycles and limited spot-market flexibility.

Near-term, the stock likely needs evidence that AI mix dilution has stabilized and that VMware bookings/cash conversion remain intact; otherwise investors may treat strong top-line growth as lower-quality revenue. Over 6-18 months, the more important catalyst is confirmation that custom silicon is expanding the total accelerator market rather than merely displacing GPU spending. The contrarian view is that consensus may be underestimating this displacement risk for NVDA, while overstating AVGO's immunity to a hyperscaler capex reset: both depend on the same concentrated buyer base.

Key Decisions for Investors

• Accumulate AVGO on post-earnings or broad semiconductor pullbacks over the next 1-3 months; target a 12-18 month holding period, with thesis supported by continued EPS estimate revisions rather than further P/E expansion.
• Express relative custom-silicon adoption via long AVGO / short MARV in equal dollar amounts for 6-12 months. AVGO has broader networking, software and cash-flow support; exit if MARV demonstrates multiple scaled customer ramps that close its execution gap.
• For a more defensive AI pair, long AVGO / short SMH at roughly 1:1 beta-adjusted exposure through the next earnings cycle. This isolates AVGO-specific estimate resilience while hedging a sector de-rating from cloud capex or rates.
• Do not add aggressively if quarterly gross-margin pressure exceeds management's ability to offset it through opex, or if a major hyperscaler signals accelerator-capex digestion. Those developments would challenge the earnings-quality premise and likely drive multiple compression before revenue estimates reset.